product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
USP9X Antibody
catalog :
5751S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot
citations: 3
Published Application/Species/DilutionReference
  • western blot (knockdown validation); human; fig 3
Cui J, Sun W, Hao X, Wei M, Su X, Zhang Y, et al. EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells. Cancer Cell Int. 2015;15:4 pubmed publisher
Yan J, Zhong N, Liu G, Chen K, Liu X, Su L, et al. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death Dis. 2014;5:e1316 pubmed publisher
Shen G, Lin Y, Yang X, Zhang J, Xu Z, Jia H. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X. BMC Cancer. 2014;14:393 pubmed publisher
product information
SKU :
5751S
Product-Name :
USP9X Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk, Dg
Applications :
Western blot
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
270
Host :
Rabbit
Target :
USP9X
Primary-Protein :
USP9X
Alt-Names :
DFFRX,Deubiquitinating enzyme FAF-X,Drosophila fat facets related, X-linked,FAF,FAM,Fat facets in mammals,Fat facets protein-related, X-linked,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,USP9,USP9X,Ubiquitin thioesterase FAF-X,Ubiquitin-specific protease 9, X chromosome,Ubiquitin-specific-processing protease FAF-X,fat facets protein related, X-linked,hFAM,ubiquitin specific peptidase 9, X-linked,ubiquitin specific protease 9, X chromosome (fat facets-like Drosophila),ubiquitin thiolesterase FAF-X,ubiquitin-specific processing protease FAF-X
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.